Denmark· DK-28101715494
Clarinase
A pseudoephedrin, kombinationen product containing loratadin, pseudoephedrinsulfat, registered in Denmark by Merck Sharp & Dohme B.V.. The same ATC class is registered in 10 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Pseudoephedrin, kombinationen is registered in 10 of 19 countries.
Countries holding a registration under ATC R01BA52 (pseudoephedrin, kombinationen), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 6 of them publish a price we can compare per daily dose
Pseudoephedrin, kombinationen · ATC R01BA52
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Statesprice
Price per daily dose
What a daily dose of pseudoephedrin, kombinationen costs, country by country.
Normalised to the WHO defined daily dose (0.24 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pseudoephedrin, kombinationen · price per daily dose (0.24 g)
USD · FX 28 Sept 2026
- US United States$0.62 (acquisition cost)
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- LORATADIN, Pseudoephedrinsulfat
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Denmark (DK)
- ATC code
- R01BA52
- ATC class
- Pseudoephedrin, Kombinationen
- Defined daily dose
- 0.24 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28101715494
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for pseudoephedrin, kombinationen.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pseudoephedrin, kombinationen · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under R01BA52
Pseudoephedrin, kombinationen, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f7632061-2f54-4096-bf63-9fedb98391be GET /v1/drugs/f7632061-2f54-4096-bf63-9fedb98391be?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "depottabletter",
"source": "dkma",
"strength": "240+10 mg",
"auth_role": "CMS",
"dk_drugid": "28101715494",
"substance": "LORATADIN, Pseudoephedrinsulfat",
"auth_procedure": "MRP",
"in_medicinpriser": false,
"registration_date_serial": "35237"
}See everything about pseudoephedrin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.